**Core Concept:**
The question pertains to a child with clinical features indicating a potential inherited neurometabolic disorder. These features include failure to thrive, progressive neurologic deterioration (deafness and blindness), and characteristic physical findings (hepatosplenomegaly and cherry-red spot). Metabolic disorders can cause a wide range of symptoms and signs due to the involvement of various organ systems.

**Why the Correct Answer is Right:**
The correct answer, **D.** Maple Syrup Urine Disease (MSUD), is a rare autosomal recessive disorder caused by deficiency of branched-chain α-keto acid dehydrogenase enzyme. This enzyme is involved in the catabolism of branched-chain amino acids (leucine, isoleucine, and valine). The symptoms and signs in this case are due to the accumulation of branched-chain α-keto acids (α-KG) in the body, which results in neurologic dysfunction, hepatosplenomegaly, and the characteristic fundoscopic finding of a "cherry-red spot."

**Why Each Wrong Option is Incorrect:**
A. **C.** Glycogen Storage Disease (GSD) type 1a is a different disorder caused by deficiency of glucose-6-phosphatase enzyme, leading to glycogen accumulation in liver and kidneys. This is distinct from MSUD in terms of amino acid abnormalities and clinical manifestations.
B. **D.** Tay-Sachs Disease is a lysosomal storage disorder caused by deficiency of hexosaminidase enzyme, leading to accumulation of gangliosides in the central nervous system. It is different from MSUD in terms of amino acids involved and clinical presentation.
C. **D.** Wilson Disease is a copper-metabolism disorder caused by deficiency of copper-transporting ATPase protein, leading to copper accumulation in liver, brain, and other tissues. This is distinct from MSUD in terms of amino acids involved and clinical presentation.

**Clinical Pearl:**
Maple Syrup Urine Disease (MSUD) is a crucial differential diagnosis to consider in any child presenting with neurological regression, hepatosplenomegaly, and fundoscopic findings. A thorough clinical evaluation, including laboratory testing, is essential to confirm the diagnosis and initiate appropriate management. Early diagnosis and management of MSUD can prevent severe neurological complications and long-term disability.